Diversidade no ensino da arte: reflexões sobre a prática pedagógica dos professores de arte de Meleiro - SC

Trabalho de Conclusão de Curso, apresentado para obtenção do grau de Licenciatura no curso de Artes Visuais, da Universidade do Extremo Sul Catarinense, UNESC.A pesquisa a seguir tem como título: “Diversidade no Ensino da Arte: Reflexões sobre a Prática Pedagógica dos Professores de Artes de Meleiro – SC”. Está inserida na linha de pesquisa Educação e Arte do Curso de Artes Visuais – Licenciatura da UNESC. Parte da seguinte problemática: “Como os professores de Artes, atuantes no município de Meleiro (SC), entendem a diversidade na educação escolar, e como abordam esse tema nas aulas? ”. Nesse sentido, o objetivo geral desta pesquisa foi investigar como os professores de Artes compreendem a diversidade na educação escolar, e como abordam esse tema nas aulas. Para esta investigação, foram realizadas entrevistas semiestruturadas com seis professoras de Artes do município de Meleiro, utilizando um roteiro de entrevista, com oito perguntas, referentes à diversidade e ao ensino da arte. Esta pesquisa, de abordagem qualitativa, partiu de um estudo bibliográfico sobre o ensino da arte, a diversidade e as suas temáticas, a diversidade na escola, a relação entre diversidade e o ensino da arte e o multi e interculturalismo. Para contextualizar sobre o ensino da arte, a diversidade e suas implicações na escola, trouxe como autores Ferraz e Fusari (2009), Rosa (2006), Candau (2008; 2012) e os documentos norteadores, como a Proposta Curricular de Santa Catarina (2014) e os Parâmetros Curriculares Nacionais para a Arte (1997), para as discussões sobre multi e interculturalismo, utilizei como referência as autoras Richter (2003), Rosa (2003), entre outros. Com as entrevistas, foi revelado que as professoras entrevistadas compreendem a importância de trabalhar a diversidade nas suas aulas, assim como a perspectiva de uma educação multicultural, porém foi percebido, em suas falas, insegurança para dialogar sobre esses assuntos. A partir da análise dos resultados, surgiu a necessidade de criar uma proposta de curso intitulada “Arte e Diversidade: Reflexões nas Práticas de Ensino”, que é voltada para os professores de Artes do município de Meleiro, visando promover momentos de estudos, reflexões e ampliação de repertório sobre as temáticas

Factors associated with the number of prenatal consultations of smokers and nonsmokers women answered in Porto Alegre hospitals, Brazil

Objetivo: analisar os fatores associados ao número de consultas pré-natais de mulheres tabagistas e não tabagistas. Métodos: análise transversal de uma amostra de conveniência de mulheres com histórias prévias de tabagismo e um grupo controle. A pesquisa foi aprovada pelos Comitês de Ética das instituições de origem. O desfecho foi o número de consultas pré-natais e as variáveis estudadas foram: idade materna (anos), raça (etnia), escolaridade (anos), renda familiar (reais), situação conjugal, número de filhos (prévios à gestação analisada) e o planejamento da gestação analisada. Os números de consultas prénatais foram comparados pelo teste Mann- Whitney. A regressão linear foi aplicada para avaliar o número de consultas prénatais e sua relação com as variáveis analisadas. Resultados: selecionaram-se 248 mulheres, distribuídas em controle (n=161) e tabagistas durante a gestação (n=87). Verificou-se que a mediana de idade foi 24 [20-30] anos e a escolaridade 9 [7,25-11] anos. A maioria das mulheres (71,4%) realizou mais de seis consultas pré-natais.Contatou-se maior frequência de mulheres solteiras no grupo tabagista (p=0,001). Tabagistas apresentaram menor escolaridade (p<0,0001), menor renda (p<0,0001), maior número de filhos (p=0,004), menor planejamento da gestação (p<0,0001) e menor número de consultas pré-natais (p<0,0001). O número de consultas pré-natais foi influenciado negativamente pelo tabagismo materno durante a gestação (p=0,009), pelo número de filhos (p<0,0001) e positivamente pela idade materna (p<0,0001). Conclusões: o tabagismo durante a gestação está associado a condições de maior vulnerabilidade socioeconômica, evidenciando a necessidade de um pré-natal adequado e cuidados mais intensos por profissionais de saúde para esta população.Objective: To analyze the factors associated with the number of prenatal consultations of smokers and nonsmokers women. Methods: Cross-sectional analysis of a convenience sample of women with previous historic of smoking and a control group. The study was approved by the Ethics Committee of the institutions of origin. The outcome was the number of prenatal consultations and studied variables were: maternal age (in years), race (ethnicity), education (in years), family income (in reais), marital status, number of children (prior to the current analyzed pregnancy) and planning the current pregnancy. Prenatal consultations frequencies were compared by Mann- Whitney test. Linear regression was used to assess the number of prenatal consultations and its relation to the analyzed variables. Results: 248 women were selected, distributed in control (n=161) and smokers during pregnancy (n=87). It was found that the age median was 24 [20-30] years and the educational level was 9 [7.25 to 11] years. Most women (71.4%) performed more than six prenatal consultations. It was observed a higher frequency of single women among smoker mothers (p=0.001). Smoker mothers displayed lower education period (p<0.0001), lower familiar income (p<0.0001), higher number of children (p=0.004), lower planning pregnancy (p<0.0001) and fewer prenatal consultations (p<0.0001). The number of prenatal consultations was negatively influenced by maternal smoking (p=0.009), number of children (p<0.0001) and positively modulated by maternal age (p<0.0001). Conclusions: smoking during pregnancy is associated with conditions of greater socioeconomic vulnerability, demonstrating the need for adequate prenatal care and more intense care by health professional for this population

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial

Aim: Patients with diabetes mellitus are at high risk of adverse events after percutaneous revascularization, with no differences in outcomes between most contemporary drug-eluting stents. The Cre8 EVO stent releases a formulation of sirolimus with an amphiphilic carrier from laser-dug wells, and has shown clinical benefits in diabetes. We aimed to compare Cre8 EVO stents to Resolute Onyx stents (a contemporary polymer-based zotarolimus-eluting stent) in patients with diabetes. Methods and results: We did an investigator-initiated, randomized, controlled, assessor-blinded trial at 23 sites in Spain. Eligible patients had diabetes and required percutaneous coronary intervention. A total of 1175 patients were randomly assigned (1:1) to receive Cre8 EVO or Resolute Onyx stents. The primary endpoint was target-lesion failure, defined as a composite of cardiac death, target-vessel myocardial infarction, and clinically indicated target-lesion revascularization at 1-year follow-up. The trial had a non-inferiority design with a 4% margin for the primary endpoint. A superiority analysis was planned if non-inferiority was confirmed. There were 106 primary events, 42 (7.2%) in the Cre8 EVO group and 64 (10.9%) in the Resolute Onyx group [hazard ratio (HR) 0.65, 95% confidence interval (CI) 0.44 to 0.96; pnon-inferiority <0.001; psuperiority = 0.030]. Among the secondary endpoints, Cre8 EVO stents had significantly lower rate than Resolute Onyx stents of target-vessel failure (7.5% vs 11.1%, HR 0.67, 95% CI 0.46 to 0.99; p = 0.042). Probable or definite stent thrombosis and all-cause death were not significantly different between groups. Conclusions: In patients with diabetes, Cre8 EVO stents were non-inferior to Resolute Onyx stents with regard to target-lesion failure composite outcome. An exploratory analysis for superiority at 1 year suggests that the Cre8 EVO stents might be superior to Resolute Onyx stents with regard to the same outcome

Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion : Insight from an international STEMI registry

Background: Concerns have been raised on a potential interaction between renin-angiotensin system inhibitors (RASI) and the susceptibility to coronavirus disease 2019 (COVID-19). No data have been so far reported on the prognostic impact of RASI in patients suffering from ST-elevation myocardial infarction (STEMI) during COVID-19 pandemic, which was the aim of the present study. Methods: STEMI patients treated with primary percutaneous coronary intervention (PPCI) and enrolled in the ISACS-STEMI COVID-19 registry were included in the present sub-analysis and divided according to RASI therapy at admission. Results: Our population is represented by 6095 patients, of whom 3654 admitted in 2019 and 2441 in 2020. No difference in the prevalence of SARSCoV2 infection was observed according to RASI therapy at admission (2.5% vs 2.1%, p = 0.5), which was associated with a significantly lower mortality (adjusted OR [95% CI]=0.68 [0.51 & ndash;0.90], P = 0.006), confirmed in the analysis restricted to 2020 (adjusted OR [95% CI]=0.5[0.33 & ndash;0.74], P = 0.001). Among the 5388 patients in whom data on in-hospital medication were available, in-hospital RASI therapy was associated with a significantly lower mortality (2.1% vs 16.7%, OR [95% CI]=0.11 [0.084 & ndash;0.14], p < 0.0001), confirmed after adjustment in both periods. Among the 62 SARSCoV-2 positive patients, RASI therapy, both at admission or in-hospital, showed no prognostic effect. Conclusions: This is the first study to investigate the impact of RASI therapy on the prognosis and SARSCoV2 infection of STEMI patients undergoing PPCI during the COVID-19 pandemic. Both pre-admission and in-hospital RASI were associated with lower mortality. Among SARSCoV2-positive patients, both chronic and in-hospital RASI therapy showed no impact on survival.Peer reviewe

Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI : Results of the ISACS-STEMI COVID-19 Registry

Background: The constraints in the management of patients with ST-segment elevation myocardial infarction (STEMI) during the COVID-19 pandemic have been suggested to have severely impacted mortality levels. The aim of the current analysis is to evaluate the age-related effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI within the registry ISACS-STEMI COVID-19. Methods: This retrospective multicenter registry was performed in high-volume PPCI centers on four continents and included STEMI patients undergoing PPCI in March–June 2019 and 2020. Patients were divided according to age (< or ≥75 years). The main outcomes were the incidence and timing of PPCI, (ischemia time longer than 12 h and door-to-balloon longer than 30 min), and in-hospital or 30-day mortality. Results: We included 16,683 patients undergoing PPCI in 109 centers. In 2020, during the pandemic, there was a significant reduction in PPCI as compared to 2019 (IRR 0.843 (95%-CI: 0.825–0.861, p < 0.0001). We found a significant agerelated reduction (7%, p = 0.015), with a larger effect on elderly than on younger patients. Furthermore, we observed significantly higher 30-day mortality during the pandemic period, especially among the elderly (13.6% vs. 17.9%, adjusted HR (95% CI) = 1.55 [1.24–1.93], p < 0.001) as compared to younger patients (4.8% vs. 5.7%; adjusted HR (95% CI) = 1.25 [1.05–1.49], p = 0.013), as a potential consequence of the significantly longer ischemia time observed during the pandemic. Conclusions: The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures, with a larger reduction and a longer delay to treatment among elderly patients, which may have contributed to increase in-hospital and 30-day mortality during the pandemic

Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

Background: The constraints in the management of patients with ST-segment elevation myocardial infarction (STEMI) during the COVID-19 pandemic have been suggested to have severely impacted mortality levels. The aim of the current analysis is to evaluate the age-related effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI within the registry ISACS-STEMI COVID-19. Methods: This retrospective multicenter registry was performed in high-volume PPCI centers on four continents and included STEMI patients undergoing PPCI in March-June 2019 and 2020. Patients were divided according to age (= 75 years). The main outcomes were the incidence and timing of PPCI, (ischemia time longer than 12 h and door-to-balloon longer than 30 min), and in-hospital or 30-day mortality. Results: We included 16,683 patients undergoing PPCI in 109 centers. In 2020, during the pandemic, there was a significant reduction in PPCI as compared to 2019 (IRR 0.843 (95%-CI: 0.825-0.861, p < 0.0001). We found a significant age-related reduction (7%, p = 0.015), with a larger effect on elderly than on younger patients. Furthermore, we observed significantly higher 30-day mortality during the pandemic period, especially among the elderly (13.6% vs. 17.9%, adjusted HR (95% CI) = 1.55 [1.24-1.93], p < 0.001) as compared to younger patients (4.8% vs. 5.7%; adjusted HR (95% CI) = 1.25 [1.05-1.49], p = 0.013), as a potential consequence of the significantly longer ischemia time observed during the pandemic. Conclusions: The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures, with a larger reduction and a longer delay to treatment among elderly patients, which may have contributed to increase in-hospital and 30-day mortality during the pandemic

Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI : Insights from the ISACS–STEMI COVID-19 Registry

The so-called “smoking paradox”, conditioning lower mortality in smokers among STEMI patients, has seldom been addressed in the settings of modern primary PCI protocols. The ISACS– STEMI COVID-19 is a large-scale retrospective multicenter registry addressing in-hospital mortality, reperfusion, and 30-day mortality among primary PCI patients in the era of the COVID-19 pandemic. Among the 16,083 STEMI patients, 6819 (42.3%) patients were active smokers, 2099 (13.1%) previous smokers, and 7165 (44.6%) non-smokers. Despite the impaired preprocedural recanalization (p < 0.001), active smokers had a significantly better postprocedural TIMI flow compared with nonsmokers (p < 0.001); this was confirmed after adjustment for all baseline and procedural confounders, and the propensity score. Active smokers had a significantly lower in-hospital (p < 0.001) and 30-day (p < 0.001) mortality compared with non-smokers and previous smokers; this was confirmed after adjustment for all baseline and procedural confounders, and the propensity score. In conclusion, in our population, active smoking was significantly associated with improved epicardial recanalization and lower in-hospital and 30-day mortality compared with previous and non-smoking histor